{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:40:06Z","timestamp":1759974006336,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.medmal.2006.01.020","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T07:17:53Z","timestamp":1175152673000},"page":"479-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Le traitement des\u00a0phases secondaires et\u00a0tertiaires de\u00a0la\u00a0borr\u00e9liose de\u00a0Lyme"],"prefix":"10.1016","volume":"37","author":[{"given":"Y.","family":"Hansmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2006.01.020_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jaut.2000.0495","article-title":"Auto-immune mechanism in antibiotic treatment-resistant Lyme arthitis","volume":"16","author":"Steere","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.medmal.2006.01.020_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1469-0691.2004.00895.x","article-title":"Lyme borreliosis: from infection to autoimmunity","volume":"10","author":"Singh","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.medmal.2006.01.020_bib3","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1084\/jem.180.6.2069","article-title":"The T helper response in Lyme arthritis: differential recognition of Borrelia\u00a0burgdorferi outer surface protein A in patients with treatment-resistant or treatment responsive Lyme arthritis","volume":"180","author":"Lengl-Janssen","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2004.06.005","article-title":"Molecular characterization of the OspA 161-175 T cell epitope associated with treatment resistant Lyme arthritis: differences among the three pathogenic species of Borrelia\u00a0burgdorferi sensu lato","volume":"23","author":"Drouin","year":"2004","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.medmal.2006.01.020_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/infdis\/171.2.356","article-title":"Biliary complications in the treatment of unsubstantiated Lyme disease","volume":"171","author":"Ettestad","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann. Intern. Med."},{"issue":"S1","key":"10.1016\/j.medmal.2006.01.020_bib7","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia\u00a0burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07853899909115982","article-title":"Borrelia\u00a0burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis","volume":"31","author":"Oksi","year":"1999","journal-title":"Ann. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0924-8579(00)00116-3","article-title":"Colorimetric in vitro susceptibility of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia\u00a0burgdorferi isolates","volume":"15","author":"Hunfeld","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.medmal.2006.01.020_bib11","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.34.11.2133","article-title":"Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia\u00a0burgdorferi to cefuroxime and other antimicrobial agents","volume":"34","author":"Johnson","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0924-8579(00)00342-3","article-title":"In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia\u00a0burgdorferi","volume":"17","author":"Hunfeld","year":"2001","journal-title":"Intern. J. Antimicrob. Agents"},{"key":"10.1016\/j.medmal.2006.01.020_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s101560050053","article-title":"In vitro and in vivo susceptibilities of Lyme disease Borrelia isolated in China","volume":"6","author":"Muqing","year":"2000","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.48.1.344-347.2004","article-title":"Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia\u00a0burgdorferi","volume":"48","author":"Hunfeld","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.37.6.1329","article-title":"Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo","volume":"37","author":"Alder","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/AAC.37.7.1444","article-title":"In vitro susceptibility of Borrelia\u00a0burgdorferi to 11 antimicrobial agents","volume":"37","author":"Levin","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib17","first-page":"193","article-title":"Sensitivity of Borrelia and Leptospira to quinupristin\u2013dalfopristin in vitro","volume":"24","author":"Murgia","year":"2001","journal-title":"New Microbiol."},{"key":"10.1016\/j.medmal.2006.01.020_bib18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF02471911","article-title":"In vitro activity of trimethoprim against Borrelia\u00a0burgdorferi","volume":"16","author":"Reisinger","year":"1997","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijantimicag.2005.02.007","article-title":"Susceptibility of Borrelia\u00a0afzelii strains to antimicrobial agents","volume":"25","author":"Ruzic-Sabljic","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.medmal.2006.01.020_bib20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/AAC.45.3.936-937.2001","article-title":"Efficacy of evernimicin (SCH27899) in vitro and in an animal model of Lyme disease","volume":"45","author":"Pavia","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib21","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1128\/AAC.46.11.3637-3640.2002","article-title":"Erythromycin resistance in Borrelia\u00a0burgdorferi","volume":"46","author":"Terekhova","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/AAC.49.4.1294-1301.2005","article-title":"In vitro susceptibility testing of Borrelia\u00a0burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy","volume":"49","author":"Hunfeld","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/AAC.33.7.1078","article-title":"Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis","volume":"33","author":"Dotevall","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib24","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1128\/AAC.40.11.2632","article-title":"In vivo activities of ceftriaxone and vancomycin against Borrelia spp. In the mouse brain and other sites","volume":"40","author":"Kazragis","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1128\/AAC.38.7.1567","article-title":"Effectiveness of antimicrobial treatment against Borrelia\u00a0burgdorferi infection in mice","volume":"38","author":"Moody","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/AAC.46.1.132-134.2002","article-title":"Efficacy of short-course therapy for Borrelia\u00a0burgdorferi infection in C3H mice","volume":"46","author":"Pavia","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.medmal.2006.01.020_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-99-6-767","article-title":"Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin","volume":"99","author":"Steere","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198504043121401","article-title":"Successful parenteral penicillin therapy of established Lyme arthritis","volume":"312","author":"Steere","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3476(86)80688-6","article-title":"Childhood arthritis: experience in an endemic area","volume":"109","author":"Eichenfield","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.medmal.2006.01.020_bib30","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/155.6.1322","article-title":"Ceftriaxone as effective therapy in refractory Lyme disease","volume":"155","author":"Dattwyler","year":"1987","journal-title":"J. Infect. Dis."},{"issue":"8596","key":"10.1016\/j.medmal.2006.01.020_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.01.020_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01644967","article-title":"Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children a prospective study","volume":"19","author":"Mulleger","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.020_bib33","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.1989.00520470044025","article-title":"Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis: a prospective randomized study","volume":"46","author":"Pfister","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.medmal.2006.01.020_bib34","first-page":"279","article-title":"Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis","volume":"19","author":"Pfister","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis","volume":"37","author":"Borg","year":"2005","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme borreliosis","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.medmal.2006.01.020_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/314860","article-title":"Successful treatment of Lyme encephalopathy with intravenous ceftriaxone","volume":"180","author":"Logigian","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib39","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","article-title":"Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis","volume":"28","author":"Dotevall","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF01780667","article-title":"Ceftriaxone in the treatment of Lyme neuroborreliosis","volume":"24","author":"Rohacova","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.020_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00115-003-1560-z","article-title":"Verlauf der akuten une chronischen Neuroborreliose nach behandlung mit ceftriaxon","volume":"75","author":"Kaiser","year":"2004","journal-title":"Nervenarzt"},{"key":"10.1016\/j.medmal.2006.01.020_bib43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/00006454-200212000-00011","article-title":"Successful treatment of neuroborreliosis with ten day regimens","volume":"21","author":"Thorstrand","year":"2002","journal-title":"Pediatr. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib44","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinte.1990.00040031677015","article-title":"Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial","volume":"150","author":"Caperton","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib45","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of Lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medmal.2006.01.020_bib46","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.51.8.1007","article-title":"Long-term treatment of chronic Lyme arthritis with benzathine penicillin","volume":"51","author":"Cimmino","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199707313370525","article-title":"Cost-effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease of Lyme arthritis","volume":"337","author":"Eckman","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s100960050166","article-title":"Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis","volume":"17","author":"Oksi","year":"1998","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1297-319X(03)00160-X","article-title":"Good outcomes of Lyme arthritis in 24 patients in an endemic area of Switzerland","volume":"71","author":"Renaud","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.medmal.2006.01.020_bib50","first-page":"98","article-title":"Long-term results in patients with Lyme arthritis following treatment with ceftriaxone","volume":"24","author":"Valesova","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.020_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.medmal.2006.01.020_bib52","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function inj post-treatment Lyme disease. Do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.medmal.2006.01.020_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medmal.2006.01.020_bib54","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD). A randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.medmal.2006.01.020_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01780666","article-title":"Success and failure in the treatment of acrodermatitis chronica atrophicans","volume":"24","author":"Aberer","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2006.01.020_bib56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1988.tb31867.x","article-title":"Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans","volume":"539","author":"Weber","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.medmal.2006.01.020_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1600-0404.2002.01336.x","article-title":"Peripheral neuropathy in acrodermatitis chronica atyrophicans: effect of treatment","volume":"106","author":"Kindstrand","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.medmal.2006.01.020_bib58","first-page":"136","article-title":"Macrolide therapy of chronic Lyme disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med. Sci. Monit."},{"issue":"suppl","key":"10.1016\/j.medmal.2006.01.020_bib59","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/314053","article-title":"Practice guidelines for the treatment of Lyme disease","volume":"31","author":"Wormser","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.01.020_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1966.00470140003001","article-title":"Blood-brain and CSF barriers to penicillin and related organic acids","volume":"15","author":"Fishman","year":"1966","journal-title":"Arch. Neurol."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:02:48Z","timestamp":1759971768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X07000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":60,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0399077X07000625"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2006.01.020","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le traitement des\u00a0phases secondaires et\u00a0tertiaires de\u00a0la\u00a0borr\u00e9liose de\u00a0Lyme","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2006.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}